21551

    540679

    HALEOSLABS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Haleos Labs Limited Share Price Today

    HALEOS LABS LIMITED is currently trading at ₹1558, up by ₹11.19 from the previous close. The stock touched an intraday high of ₹1585.90 and a low of ₹1536.40 during the latest trading session. Over the past one year, HALEOS LABS LIMITED has delivered a return of 33.53%, while the stock has gained 18.83% in the last one month.

    Haleos Labs Limited performance

    Today’s low Today’s high
    ₹ 1536.40 ₹ 1585.90
    ₹ 1544.30
    52 week low 52 week high
    ₹ 1067.00 ₹ 1774.00
    ₹ 1544.30
    Open Price ₹ 1538.90
    Prev. Close ₹ 1546.80
    Volume (Shares) 95.00
    Total traded value ₹ 1.46
    Upper Circuit ₹ 1856.10
    Lower Circuit ₹ 1237.50
    info

    Investment Returns

    Over 1 Month 18.83% Over 3 Months 25.12% Over 6 Months 21.77% Over 1 Year 33.53%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Haleos Labs Limited fundamentals


    • Market cap (Cr) 466.90
    • P/E Ratio (TTM) 26.36
    • Beta 0.52
    • Book Value / share 709.73
    • Return on equity 11.45%
    • EPS (TTM) 58.80
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 2.23
    info icon alternate text
    • Market cap (Cr) 468.60
    • P/E Ratio (TTM) 26.36
    • Beta 0.45
    • Book Value / share 709.73
    • Return on equity 11.45%
    • EPS (TTM) 58.80
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 2.23
    info icon alternate text

    Haleos Labs Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 63.38
    Operating Expense 61.18
    Net Profit 2.23
    Net Profit Margin (%) 3.51
    Earnings Per Share (EPS) 7.39
    EBITDA 7.18
    Effective Tax Rate (%) 29.55
    Particulars DEC 2025 (Values in Cr)
    Revenue 80.72
    Operating Expense 73.30
    Net Profit 5.41
    Net Profit Margin (%) 6.70
    Earnings Per Share (EPS) 17.88
    EBITDA 11.63
    Effective Tax Rate (%) 27.77
    Particulars SEP 2025 (Values in Cr)
    Revenue 77.84
    Operating Expense 71.24
    Net Profit 4.98
    Net Profit Margin (%) 6.39
    Earnings Per Share (EPS) 16.46
    EBITDA 11.24
    Effective Tax Rate (%) 29.36
    Particulars JUN 2025 (Values in Cr)
    Revenue 79.04
    Operating Expense 72.57
    Net Profit 5.16
    Net Profit Margin (%) 6.52
    Earnings Per Share (EPS) 17.06
    EBITDA 11.84
    Effective Tax Rate (%) 31.01
    Particulars MAR 2025 (Values in Cr)
    Revenue 85.43
    Operating Expense 84.29
    Net Profit 2.68
    Net Profit Margin (%) 3.13
    Earnings Per Share (EPS) 8.85
    EBITDA 7.79
    Effective Tax Rate (%) 19.81
    Particulars MAR 2026 (Values in Cr)
    Revenue 300.99
    Operating Expense 277.21
    Net Profit 17.78
    Net Profit Margin (%) 5.90
    Earnings Per Share (EPS) 58.80
    EBITDA 41.88
    Effective Tax Rate (%) 29.41
    Particulars MAR 2025 (Values in Cr)
    Revenue 333.37
    Operating Expense 307.27
    Net Profit 21.37
    Net Profit Margin (%) 6.41
    Earnings Per Share (EPS) 70.69
    EBITDA 48.18
    Effective Tax Rate (%) 28.86
    Particulars MAR 2024 (Values in Cr)
    Revenue 300.00
    Operating Expense 284.71
    Net Profit 13.07
    Net Profit Margin (%) 4.35
    Earnings Per Share (EPS) 43.22
    EBITDA 38.26
    Effective Tax Rate (%) 31.65
    Particulars MAR 2023 (Values in Cr)
    Revenue 315.24
    Operating Expense 302.09
    Net Profit 13.22
    Net Profit Margin (%) 4.19
    Earnings Per Share (EPS) 43.72
    EBITDA 31.63
    Effective Tax Rate (%) 28.03
    Particulars MAR 2022 (Values in Cr)
    Revenue 345.63
    Operating Expense 326.88
    Net Profit 25.38
    Net Profit Margin (%) 7.34
    Earnings Per Share (EPS) 83.95
    EBITDA 45.60
    Effective Tax Rate (%) 23.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 650.15
    ROE % 10.03
    ROCE % 12.26
    Total Debt to Total Equity 0.50
    EBITDA Margin 12.94
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 584.84
    ROE % 3.67
    ROCE % 7.24
    Total Debt to Total Equity 0.58
    EBITDA Margin 10.34
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 557.71
    ROE % 6.12
    ROCE % 8.31
    Total Debt to Total Equity 0.56
    EBITDA Margin 8.91
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 503.53
    ROE % 11.26
    ROCE % 11.95
    Total Debt to Total Equity 0.51
    EBITDA Margin 9.31
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 427.40
    ROE % 11.07
    ROCE % 12.53
    Total Debt to Total Equity 0.53
    EBITDA Margin 10.85
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 652.19
    ROE % 11.45
    ROCE % 13.69
    Total Debt to Total Equity 0.46
    EBITDA Margin 13.10
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 582.90
    ROE % 7.68
    ROCE % 10.68
    Total Debt to Total Equity 0.53
    EBITDA Margin 11.67
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 542.55
    ROE % 7.20
    ROCE % 8.85
    Total Debt to Total Equity 0.47
    EBITDA Margin 8.25
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 500.16
    ROE % 11.47
    ROCE % 12.54
    Total Debt to Total Equity 0.39
    EBITDA Margin 8.67
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 417.88
    ROE % 10.99
    ROCE % 13.83
    Total Debt to Total Equity 0.40
    EBITDA Margin 10.85
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.50
    Total Assets 389.99
    Total Liabilities 389.99
    Total Equity 212.04
    Share Outstanding 0
    Price to Book Ratio 1.66
    Return on Assets (%) 5.15
    Return on Capital (%) 6.79
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.49
    Total Assets 391.32
    Total Liabilities 391.32
    Total Equity 193.63
    Share Outstanding 0
    Price to Book Ratio 1.16
    Return on Assets (%) 2.32
    Return on Capital (%) 3.12
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 4.41
    Total Assets 394.89
    Total Liabilities 394.89
    Total Equity 188.21
    Share Outstanding 0
    Price to Book Ratio 0.96
    Return on Assets (%) 2.90
    Return on Capital (%) 4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.39
    Total Assets 356.74
    Total Liabilities 356.74
    Total Equity 164.92
    Share Outstanding 0
    Price to Book Ratio 1.39
    Return on Assets (%) 7.09
    Return on Capital (%) 10.46
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 11.06
    Total Assets 302.29
    Total Liabilities 302.29
    Total Equity 129.21
    Share Outstanding 0
    Price to Book Ratio 1.18
    Return on Assets (%) 4.48
    Return on Capital (%) 7.01
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.40
    Total Assets 358.31
    Total Liabilities 358.31
    Total Equity 197.17
    Share Outstanding 0
    Price to Book Ratio 1.66
    Return on Assets (%) 5.96
    Return on Capital (%) 7.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.25
    Total Assets 348.23
    Total Liabilities 348.23
    Total Equity 176.22
    Share Outstanding 0
    Price to Book Ratio 1.16
    Return on Assets (%) 3.75
    Return on Capital (%) 4.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.95
    Total Assets 337.38
    Total Liabilities 337.38
    Total Equity 164.02
    Share Outstanding 0
    Price to Book Ratio 0.96
    Return on Assets (%) 3.91
    Return on Capital (%) 5.3
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.13
    Total Assets 312.00
    Total Liabilities 312.00
    Total Equity 151.21
    Share Outstanding 0
    Price to Book Ratio 1.39
    Return on Assets (%) 8.13
    Return on Capital (%) 12.03
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 8.90
    Total Assets 271.74
    Total Liabilities 271.74
    Total Equity 126.33
    Share Outstanding 0
    Price to Book Ratio 1.18
    Return on Assets (%) 4.84
    Return on Capital (%) 7.71
    Particulars MAR 2025 (Values in Cr)
    Net Income 26.18
    Cash from Operations 42.55
    Cash from Investing -14.99
    Cash from Financing -19.12
    Net change in Cash -0.06
    Free Cash Flow 57.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 9.84
    Cash from Operations 27.30
    Cash from Investing -18.45
    Cash from Financing -6.56
    Net change in Cash -0.70
    Free Cash Flow 48.17
    Particulars MAR 2023 (Values in Cr)
    Net Income 14.24
    Cash from Operations 17.95
    Cash from Investing -31.29
    Cash from Financing 16.88
    Net change in Cash 0.29
    Free Cash Flow 66.50
    Particulars MAR 2022 (Values in Cr)
    Net Income 20.03
    Cash from Operations -3.53
    Cash from Investing -7.14
    Cash from Financing 10.83
    Net change in Cash -7.55
    Free Cash Flow 47.61
    Particulars MAR 2021 (Values in Cr)
    Net Income 19.56
    Cash from Operations 40.10
    Cash from Investing -26.23
    Cash from Financing -2.54
    Net change in Cash 6.38
    Free Cash Flow 75.66
    Particulars MAR 2025 (Values in Cr)
    Net Income 30.04
    Cash from Operations 36.53
    Cash from Investing -13.76
    Cash from Financing -14.20
    Net change in Cash 0.06
    Free Cash Flow 50.61
    Particulars MAR 2024 (Values in Cr)
    Net Income 19.11
    Cash from Operations 17.75
    Cash from Investing -13.74
    Cash from Financing -0.81
    Net change in Cash 0.18
    Free Cash Flow 31.47
    Particulars MAR 2023 (Values in Cr)
    Net Income 16.02
    Cash from Operations 8.07
    Cash from Investing -27.96
    Cash from Financing 22.59
    Net change in Cash -0.79
    Free Cash Flow 41.98
    Particulars MAR 2022 (Values in Cr)
    Net Income 20.28
    Cash from Operations -7.09
    Cash from Investing -7.48
    Cash from Financing 14.62
    Net change in Cash -7.51
    Free Cash Flow 17.86
    Particulars MAR 2021 (Values in Cr)
    Net Income 19.35
    Cash from Operations 26.22
    Cash from Investing -5.94
    Cash from Financing -7.86
    Net change in Cash 7.80
    Free Cash Flow 39.54
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8200.05 107.09 23.48 20500.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90

    Haleos Labs Limited shareholding pattern

    Holding
    27.59%
    72.1%
    0.29%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Haleos Labs Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1544.30 -0.16 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 1596.70
    • 26 Days 1496.10
    • 10 Days 1547.80
    • 50 Days 1468.00
    • 12 Days 1534.40
    • 100 Days 1416.20
    • 20 Days 1505.70
    • 200 Days 1352.30
    1626.87 PIVOT
    First Support 1588.53 First Resistance 1650.63 Second Support 1564.77 Second Resistance 1688.97 Third Support 1526.43 Third Resistance 1712.73
    RSI 61.17 ADX 30.69 MACD 38.33 Williams % R -29.84 Commodity Channel Index (CCI) 129.54
    Date 2026-07-07 Week 2124.00 Same Day 641.00 Month 1088.00
    1 Year 0.52 3 Year 0.77
    Over 1 Month
    18.83% down
    Over 1 Year
    33.53% down
    Over 3 Months
    25.12% down
    Over 3 Years
    46.23% down
    Over 6 Months
    21.77% down
    Over 5 Years
    16.54% down

    Haleos Labs Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Sep 2025 1.5 Final 24 Sep 2025 Equity shares
    23 Sep 2024 1.5 Final 23 Sep 2024 Equity shares
    22 Sep 2023 1.5 Final 23 Sep 2023 Equity shares
    22 Sep 2022 1.5 Final 24 Sep 2022 Equity shares
    20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Sep 2025 1.5 Final 24 Sep 2025 Equity shares
    23 Sep 2024 1.5 Final 23 Sep 2024 Equity shares
    22 Sep 2023 1.5 Final 23 Sep 2023 Equity shares
    22 Sep 2022 1.5 Final 24 Sep 2022 Equity shares
    20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Haleos Labs Limited?

    Answer Field

    Haleos Labs Limited share price is for NSE ₹ 1,558.00 & for BSE ₹ 1,552.95 as on Jul 09 2026 03:29 PM.

    What is the Market Cap of Haleos Labs Limited Share?

    Answer Field

    The market cap of Haleos Labs Limited for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 09 2026 03:29 PM.

    What is the 52 Week High and Low of Haleos Labs Limited?

    Answer Field

    The 52 Week High and Low of Haleos Labs Limited for NSE is ₹ 1,774.00 and ₹ 1,067.00 and for BSE is ₹ 1,778.35 and ₹ 1,050.05.

    What is 1 year return for Haleos Labs Limited?

    Answer Field

    The 1 year returns on the stock has been 28.25%.

    What is the P/E Ratio of Haleos Labs Limited Share?

    Answer Field

    As on Jul 09 2026 03:29 PM the price-to-earnings (PE) ratio for Haleos Labs Limited share is 26.36.

    What is the PB ratio of Haleos Labs Limited Share?

    Answer Field

    As on Jul 09 2026 03:29 PM, the price-to-book (PB) ratio for Haleos Labs Limited share is 709.73.

    How to Buy Haleos Labs Limited Share?

    Answer Field

    You can trade in Haleos Labs Limited shares with Bajaj Broking by opening a demat account.

    How to Buy Haleos Labs Limited Share on Bajaj Broking App?

    Answer Field

    To buy Haleos Labs Limited shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Haleos Labs Limited”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |